Mumps outbreak and laboratory diagnosis

Journal of Clinical Virology

Volumn 62, Issue , 2015, Pages 14-19

  Maillet, Mylène ^a   Bouvat, Eric ^b   Robert, Nicole ^b   Baccard Longère, Monique ^a   Morel Baccard, Christine ^a   Morand, Patrice ^a,c   Vabret, Astrid ^d   Stahl, Jean Paul ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Inter University Health Center   (France)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Mumps outbreak; Mumps reverse transcriptase polymerase chain reaction; Mumps serological test; Mumps vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; ENZYME IMMUNOASSAY; EPIDEMIC; FEMALE; FEVER; FRANCE; GENOTYPE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MUMPS; ORCHITIS; OVARY INFLAMMATION; PAROTITIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; ADOLESCENT; BLOOD; CLASSIFICATION; GENETICS; IMMUNOLOGY; MICROBIOLOGICAL EXAMINATION; MOLECULAR TYPING; MUMPS VIRUS; SEASON; SEROTYPING; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DISEASE OUTBREAKS; FEMALE; FRANCE; HUMANS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MICROBIOLOGICAL TECHNIQUES; MOLECULAR TYPING; MUMPS; MUMPS VIRUS; SEASONS; SEROTYPING; YOUNG ADULT;

EID: 84920407474     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.11.004     Document Type: Article

References (24)

1. Coffinieres E., Turbelin C., Riblier D., Aouba A., Levy-Bruhl D., Arena C., et al. Mumps: burden of disease in France. Vaccine 2012, 30:7013-7018.
2. Hukic M., Ravlija J., Dedeic Ljubovic A., Moro A., Arapcic S., Muller C.P., et al. Ongoing large mumps outbreak in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina, December 2010 to July 2011. Euro Surveill 2011, 16. pii:19959.
3. Rajcevic S., Seguljev Z., Petrovic V., Medic S., Nedelijkovic J., Milosevic V., et al. Ongoing mumps outbreak in Novi Sad, the autonomous province of Vojvodina, Serbia, January to April 2012. Euro Surveill 2012, 17. pii:20169.
4. Barskey A.E., Schulte C., Rosen J.B., Handschur E.F., Rausch-Phung E., Doll M.K., et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012, 367:1704-1713.
5. Dayan G.H., Quinlisk M.P., Parker A.A., Barskey A.E., Harris M.L., Hill Schwartz J.M., et al. Recent resurgence of mumps in the United States. N Engl J Med 2008, 358:1580-1589.
6. Cortese M.M., Jordan H.T., Curns A.T., Quinlan P.A., Ens K.A., Denning P.M., et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008, 46:1172-1180.
7. Dayan G.H., Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?. Clin Infect Dis 2008, 47:1458-1467.
8. Vandermeulen C., Roelants M., Vermoere M., Roseeuw K., Goubau P., Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure?. Vaccine 2004, 22:2713-2716.
9. Rota J.S., Turner J.C., Yost-Daljev M.K., Freeman M., Toney D.M., Meisel E., et al. Investigation of a mumps outbreak among university students with two Measles-Mumps-Rmeasles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol 2009, 81:1819-1825.
10. Rota J.S., Rosen J.B., Doll M.K., McNall R.J., McGrew M., Williams N., et al. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York City in 2009. Clin Vaccine Immunol 2013, 20(March (3)):391-396.
11. Bitsko R.H., Cortese M.M., Dayan G.H., Rota P.A., Lowe L., Iversen S.C., et al. Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol 2008, 46:1101-1103.
12. Briss P.A., Fehrs L.J., Parker R.A., Wright P.F., Sannella E.C., Hutcheson R.H., et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 1994, 169(1):77-82.
13. Sanz-Moreno J.C., Limia-Sánchez A., García-Comas L., Mosquera-Guttiérez M.M., Echevarria-Mayo J.E., Castellanos-Nadal A., et al. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G. Vaccine 2005, 30(41):4921-4925.
14. Borgmann S., Schwab F., Santibanez S., Mankertz A. Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study. Epidemiol Infect 2014, 15:1-9.
15. Sanz J.C., Mosquera Mdel M., Echevarría J.E., Fernandez M., Herranz N., Palacios G., et al. Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status. APMIS 2006, 114(11):788-794.
16. Guthmann J.P., Fonteneau L., Lévy-Bruhl D. Mesure de la couverture vaccinale en France. Sources de données et données actuelles 2012, 98. Institut de veille sanitaire, Saint-Maurice.
17. Cortese M.M., Barskey A.E., Tegtmeier G.E., Zhang C., Ngo L., Kyaw M.H., et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis 2011, 2004:1413-1422.
18. Cohen C., White J.M., Savage E.J., Glynn J.R., Choi Y., Andrews N., et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007, 13:12-17.
19. Barskey A.E., Glasser J.W., LeBaron C.W. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine 2009, 27:6186-6195.
20. Ogbuanu I.U., Kutty P.K., Hudson J.M., Blog D., Abedi G.R., Goodell S., et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 2012, 130:e1567-e1574.
21. Jokinen S., Osterlund P., Julkunen I., Davidkin I. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis 2007, 196:861-867.
22. Rubin S.A., Link M.A., Sauder C.J., Ngo L., Rima B.K., Duprex P. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2012, 86:615-620.
23. Rubin S.A., Qi L., Audet S.A., Sullivan B., Carbone K.M., Bellini W.J., et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008, 198:508-515.
24. http://www.who.int/immunization/monitoringsurveillance/burden/vpd/surveillance:type/passive/mumpsstandards/en/.